SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-022470
Filing Date
2024-04-26
Accepted
2024-04-26 16:22:01
Documents
5
Period of Report
2024-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20020408x1_def14a.htm DEF 14A 519837
2 logo_ikena.jpg GRAPHIC 34202
3 sig_markmanfredi.jpg GRAPHIC 18710
4 ny20020408x1_pc01.jpg GRAPHIC 619569
5 ny20020408x1_pc02.jpg GRAPHIC 559162
  Complete submission text file 0001140361-24-022470.txt   2216121
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40287 | Film No.: 24884148
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)